Effects of aggressive lipid-lowering therapy in patients with glomerulonephritis - Statin therapy for glomerulonephritis

At the time of remission of urinary protein, both groups showed a trend toward improvement in lipid abnormalities, but EL, which was not significantly different at the time of initiation of steroid therapy, remained higher in group A than in group C from the time of remission until 1 month later. After 3 months of remission, EL was similar in the two groups, but tended to be higher than at the beginning of treatment in both groups.